Illuminating the Black Box: The Real Risk of Serious Infection With Inflammatory Bowel Disease Therapies

被引：7
|
作者：
Lynn, Amanda M. [1 ]
Loftus, Edward V., Jr. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA
来源：
GASTROENTEROLOGY | 2018年 / 155卷 / 02期
关键词：
CROHNS-DISEASE; COMBINATION THERAPY; INFLIXIMAB; AZATHIOPRINE;
D O I：
10.1053/j.gastro.2018.06.053
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：262 / 265
页数：4
相关论文
共 50 条
  • [31] Future therapies for inflammatory bowel disease
    Stephen J. Bickston
    Lawrence W. Comerford
    Fabio Cominelli
    Current Gastroenterology Reports, 2003, 5 (6) : 518 - 523
  • [32] Immunosuppressive therapies for inflammatory bowel disease
    Zenlea, Talia
    Peppercorn, Mark A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (12) : 3146 - 3152
  • [33] Biological therapies of inflammatory bowel disease
    van Deventer, SJH
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2001, 64 (02) : 177 - 181
  • [34] Communicating the Safety of Inflammatory Bowel Disease Therapies Risk Versus Reality
    Siegel, Corey A.
    GASTROENTEROLOGY NURSING, 2008, 31 (05) : S8 - S10
  • [35] Infliximab use in patients with inflammatory bowel disease and the risk of serious bacterial infections
    Schneeweiss, Sebastian
    Solomon, Daniel
    Korzenik, Joshua
    Canning, Claire
    Bressler, Brian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S62 - S62
  • [36] Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study
    Marild, Karl
    Soderling, Jonas
    Axelrad, Jordan
    Halfvarson, Jonas
    Forss, Anders
    Olen, Ola
    Ludvigsson, Jonas F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04) : 831 - 846
  • [37] Infliximab use in patients with inflammatory bowel disease and the risk of serious bacterial infections
    Bressler, Brian
    Korzenik, Joshua R.
    Canning, Claire
    Solomon, Daniel
    Schneeweiss, Sebastian
    GASTROENTEROLOGY, 2008, 134 (04) : A144 - A144
  • [38] Dietary Therapies in Pediatric Inflammatory Bowel Disease An Evolving Inflammatory Bowel Disease Paradigm
    Lane, Erin R.
    Lee, Dale
    Suskind, David L.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2017, 46 (04) : 731 - +
  • [39] Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease
    Hindryckx, Pieter
    Novak, Gregor
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 633 - 641
  • [40] Risk of Clostridioides difficile infection in patients with inflammatory bowel disease
    Martinez Lozano, H.
    Saralegui Gonzalez, P.
    Fueyo Pelaez, P. R.
    Garcia Garcia, A.
    Miranda-Bautista, J.
    Reigadas Ramirez, E.
    Alcala Hernandez, L.
    Munoz Garcia, P.
    Marin-Jimenez, I.
    Menchen, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2044 - I2044
12345